UK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalised COVID-19 patients, after encouraging topline results from a phase 2 study that started last March. The inhaled ...
UK biotech Synairgen saw the value of its shares crater after its inhaled interferon beta therapy SNG001 was found to provide no benefit to people hospitalised with COVID-19. The drug ...
COVID-19 is spread when infectious respiratory droplets and particles enter your mouth, nose or eyes in the following ways: by breathing them in when someone sneezes or coughs near your face touching ...
15, 2024 — A unique influenza vaccine candidate that's inhaled appears safe and could ... live flu virus appears to be safe and ... Nasal COVID-19 Vaccine Halts Transmission, Animal Study ...
15, 2024 — A unique influenza vaccine candidate that's inhaled appears safe and could ... live flu virus appears to be safe and ... Nasal COVID-19 Vaccine Halts Transmission, Animal Study ...